CDC-Authored Genomics and Precision Health Publications Database
Last data update: Jan 27, 2025. (Total: 6504 publications)
Query Trace: Raizes E[original query] |
---|
HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique
Ismael N , Gemusse H , Mahumane I , Laurindo O , Magul C , Baxter C , Wilkinson E , Hofstra LM , Wagar N , Bila D , Mabunda N , da Silva J , Oliveira T , Raizes E , Preiser W , Manuel P , Ramos A , Vúbil A . BMC Infect Dis 2024 24 (1) 748 ![]() |
Resistance is common in paediatric patients failing ART in South Africa
Hunt GM , Yousif M , Levin L , Ledwaba J , Steegen K , Kufa T , Zwane H , Kalimashe M , Kana V , Aynalem G , Perlman J , Ayalew K , Kindra G , Diallo K , Carmona S , Sherman G , Raizes EJ . J Antimicrob Chemother 2023 78 (5) 1160-1167 ![]() |
Pretreatment Human Immunodeficiency Virus (HIV) Drug Resistance Among Treatment-Naive Infants Newly Diagnosed With HIV in 2016 in Namibia: Results of a Nationally Representative Study.
Jordan MR , Bikinesi L , Ashipala L , Mutenda N , Brantuo M , Hunt G , Shiningavamwe A , Mutandi G , Beukes A , Beard S , Battey K , Dziuban EJ , Raizes E , Adjei P , Tang A , Giron A , Hong SY . Open Forum Infect Dis 2022 9 (5) ofac102 ![]() |
Drug resistance and use of long-acting ART.
daSilva J , Siedner M , McCluskey S , Chandiwana N , Venter F , Raizes E . Lancet HIV 2022 9 (6) e374-e375 ![]() |
HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
Bareng OT , Moyo S , Zahralban-Steele M , Maruapula D , Ditlhako T , Mokaleng B , Mokgethi P , Choga WT , Moraka NO , Pretorius-Holme M , Mine MO , Raizes E , Molebatsi K , Motswaledi MS , Gobe I , Mohammed T , Gaolathe T , Shapiro R , Mmalane M , Makhema JM , Lockman S , Essex M , Novitsky V , Gaseitsiwe S . J Antimicrob Chemother 2022 77 (5) 1385-1395 |
Monitoring emerging HIV drug resistance in sub-Saharan Africa in the era of dolutegravir.
da Silva J , Pals S , Chang J , Hackett S , Godfrey C , Raizes E . J Infect Dis 2021 225 (3) 364-366 ![]() |
HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
Watera C , Ssemwanga D , Namayanja G , Asio J , Lutalo T , Namale A , Sanyu G , Ssewanyana I , Gonzalez-Salazar JF , Nazziwa J , Nanyonjo M , Raizes E , Kabuga U , Mwangi C , Kirungi W , Musinguzi J , Mugagga K , Mbidde EK , Kaleebu P . J Antimicrob Chemother 2021 76 (9) 2407-2414 |
Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project.
Bachanas P , Alwano MG , Lebelonyane R , Block L , Behel S , Raizes E , Ussery G , Wang H , Ussery F , Pretorius Holme M , Sexton C , Pals S , Lasry A , Del Castillo L , Hader S , Lockman S , Bock N , Moore J . PLoS One 2021 16 (4) e0250211 |
HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
Moyo S , Hunt G , Zuma K , Zungu M , Marinda E , Mabaso M , Kana V , Kalimashe M , Ledwaba J , Naidoo I , Takatshana S , Matjokotja T , Dietrich C , Raizes E , Diallo K , Kindra G , Mugore L , Rehle T . PLoS One 2020 15 (11) e0241071 ![]() |
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia.
Jordan MR , Hamunime N , Bikinesi L , Sawadogo S , Agolory S , Shiningavamwe AN , Negussie T , Fisher-Walker CL , Raizes EG , Mutenda N , Hunter CJ , Dean N , Steegen K , Kana V , Carmona S , Yang C , Tang AM , Parkin N , Hong SY . Medicine (Baltimore) 2020 99 (37) e21661 ![]() |
Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study.
Onwuamah CK , Okpokwu J , Audu R , Imade G , Meloni ST , Okwuraiwe A , Chebu P , Musa AZ , Chaplin B , Dalhatu I , Agbaji O , Samuels J , Ezechi O , Ahmed M , Odaibo G , Olaleye DO , Okonkwo P , Salako BL , Raizes E , Yang C , Kanki PJ , Idigbe EO . BMC Microbiol 2020 20 (1) 17 ![]() |
Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.
Tchouwa GF , Eymard-Duvernay S , Cournil A , Lamare N , Serrano L , Butel C , Bertagnolio S , Mpoudi-Ngole E , Raizes E , Aghokeng AF . J Antimicrob Chemother 2018 73 (9) 2468-2474 ![]() |
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.
Rhee SY , Jordan MR , Raizes E , Chua A , Parkin N , Kantor R , Van Zyl GU , Mukui I , Hosseinipour MC , Frenkel LM , Ndembi N , Hamers RL , Rinke de Wit TF , Wallis CL , Gupta RK , Fokam J , Zeh C , Schapiro JM , Carmona S , Katzenstein D , Tang M , Aghokeng AF , De Oliveira T , Wensing AM , Gallant JE , Wainberg MA , Richman DD , Fitzgibbon JE , Schito M , Bertagnolio S , Yang C , Shafer RW . PLoS One 2015 10 (12) e0145772 |
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011
Jordan MR , Bennett DE , Wainberg MA , Havlir D , Hammer S , Yang C , Morris L , Peeters M , Wensing AM , Parkin N , Nachega JB , Phillips A , De Luca A , Geng E , Calmy A , Raizes E , Sandstrom P , Archibald CP , Perriens J , McClure CM , Hong SY , McMahon JH , Dedes N , Sutherland D , Bertagnolio S . Clin Infect Dis 2012 54 Suppl 4 S245-9 |
- Page last reviewed:Feb 1, 2024
- Content source: